Therapie postoperativer intraabdomineller Infektionen

ZUSAMMENFASSUNG

Postoperative intraabdominelle Infektionen (IAI) stellen eine ebenso wichtige wie heterogene Krankheitsgruppe dar, die durch bakterielle oder fungale Erreger verursacht werden. Es ist komplex, die verschiedenen Entitäten durch klare Definitionen zu differenzieren. Der vorliegende Beitrag versucht, das aktuelle Wissen bezüglich klinischer Symptomatik und mikrobieller Ökologie zusammenzufassen. Ferner wird erläutert, wie entscheidend eine frühzeitige chirurgische oder interventionelle Fokussanierung in Kombination mit einer adäquaten antibakteriellen bzw. antifungalen Therapie für die Prognose der betroffenen Patienten ist.

• Literatur

• 1 De Waele J, Lipman J, Sakr Y. et al Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome. BMC Infect Dis 2014; 14: 420
• 2 Volakli E, Spies C, Michalopoulos A. et al Infections of respiratory or abdominal origin in ICU patients: what are the differences?. Crit Care 2010; 14: R32
• 3 Bassetti M, Righi E, Ansaldi F. et al A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 2015; 41: 1601-1610
• 4 Montravers P, Blot S, Dimopoulos G, Eckmann C. et al Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med 2016; 42: 1234-1247
• 5 Bassetti M, Garnacho-Montero J, Calandra T. et al Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med 2017; 43: 1225-1238
• 6 Sartelli M, Catena F, Ansaloni L. et al Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J Emerg Surg 2014; 9: 37
• 7 Mazuski JE, Tessier JM, May AK. et al The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surg Infect (Larchmt) 2017; 18: 1-76
• 8 Sartelli M, Catena F, Abu-Zidan FM. et al Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg 2017; 12: 22
• 9 de Ruiter J, Weel J, Manusama E. et al The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection 2009; 37: 522-527
• 10 Montravers P, Guglielminotti J, Zappella N. et al Clinical features and outcome of postoperative peritonitis following bariatric surgery. Obes Surg 2013; 23: 1536-1544
• 11 Augustin P, Kermarrec N, Muller-Serieys C. et al Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care 2010; 14: R20
• 12 Montravers P, Gauzit R, Muller C. et al Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23: 486-494
• 13 Seguin P, Fedun Y, Laviolle B. et al Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother 2010; 65: 342-346
• 14 Montravers P, Dufour G, Guglielminotti J. et al Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis. Crit Care 2015; 19: 70
• 15 Blot S, Antonelli M, Arvaniti K. et al for the Abdominal Sepsis Study (AbSeS) group for the Trials Group of the European Society of Intensive Care Medicine. Epidemiology of Intra-Abdominal Infection and Sepsis in Critically Ill Patients: the Multinational “AbSeS” Study, an ESICM Trials Group Project. Intensive Care Medicine 2019 (accepted for publication)
• 16 Bassetti M, Giacobbe DR, Vena A. et al Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Critical Care 2019; 23: 219
• 17 Dupont H, Bourichon A, Paugam-Burtz C. et al Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?. Crit Care Med 2003; 31: 752-757
• 18 Montravers P, Mira JP, Gangneux JP. et al A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 2011; 17: 1061-1067
• 19 Bassetti M, Marchetti M, Chakrabarti A. et al A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 2013; 39: 2092-2106
• 20 Bassetti M, Scudeller L, Giacobbe DR. et al Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses 2018
• 21 Eckmann C, Dryden M, Montravers P. et al Antimicrobial treatment of „complicated“ intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions. Eur J Med Res 2011; 16: 115-126
• 22 Sartelli M, Weber DG, Ruppe E. et al Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg 2016; 11: 33
• 23 Solomkin JS, Mazuski JE, Bradley JS. et al Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 133-164
• 24 Zhao N, Li Q, Cui J, Yang Z. et al CT-guided special approaches of drainage for intraabdominal and pelvic abscesses: One single center‘s experience and review of literature. Medicine (Baltimore) 2018; 97: e12905
• 25 Montravers P, Lepape A, Dubreuil L. et al Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009; 63: 785-794
• 26 Eckmann C, Kaffarnik M, Schappacher M. et al Multiresistente gramnegative Bakterien: Klinischer Managementpfad für Patienten mit elektiven Eingriffen in der Viszeralchirurgie. Chirurg 2017; 89: 40-49
• 27 Eckmann C, Montravers P, Bassetti M. et al Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother 2013; 68 (Suppl. 02) ii25-35
• 28 Harris PNA, Tambyah PA, Lye DC. et al Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA 2018; 320: 984-994
• 29 Mazuski JE, Gasink LB, Armstrong J. et al Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program. Clin Infect Dis 2016; 62: 1380-1389
• 30 Solomkin J, Hershberger E, Miller B. et al Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). Clin Infect Dis 2015; 60: 1462-1471
• 31 Bassetti M, Giacobbe DR, Patel N. et al Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis. Adv Ther 2019; 36: 1771-1777
• 32 Solomkin JS, Gardovskis J, Lawrence K. et al IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections. Clin Infect Dis 2019; 69: 921-929
• 33 Bassetti M, Peghin M, Vena A. et al Treatment of Infections Due to MDR Gram-Negative Bacteria. Frontiers in Medicine 2019; 6: 74
• 34 Giacobbe DR, Bassetti M, De Rosa FG. et al Ceftolozane/tazobactam: place in therapy. Expert Rev Anti Infect Ther 2018; 16: 307-320
• 35 Sterling SA, Miller WR, Pryor J. et al The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med 2015; 43: 1907-1915
• 36 Sawyer RG, Claridge JA, Nathens AB. et al Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015; 372: 1996-2005
• 37 Montravers P, Tubach F, Lescot T. et al Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med 2018; 44: 300-310
• 38 Martin-Loeches I, Timsit JF, Leone M. et al Clinical controversies in abdominal sepsis. Insights for critical care settings. J Crit Care 2019; 53: 53-58
• 39 Rhodes A, Evans LE, Alhazzani W. et al Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017; 43: 304-377
• 40 Azuhata T, Kinoshita K, Kawano D. et al Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care 2014; 18: R87
• 41 Bloos F, Ruddel H, Thomas-Ruddel D. et al Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive Care Med 2017; 43: 1602-1612
• 42 Azzarello G, Lanteri R, Rapisarda C. et al Ultrasound-guided percutaneous treatment of abdominal collections. Chir Ital 2009; 61: 337-340
• 43 Bufalari A, Giustozzi G, Moggi L. et al Postoperative intraabdominal abscesses: percutaneous versus surgical treatment. Acta Chir Belg 1996; 96: 197-200
• 44 Jaffe TA, Nelson RC, Delong DM. et al Practice patterns in percutaneous image-guided intraabdominal abscess drainage: survey of academic and private practice centers. Radiology 2004; 233: 750-756
• 45 vanSonnenberg E, Wing VW, Casola G. et al Temporizing effect of percutaneous drainage of complicated abscesses in critically ill patients. AJR Am J Roentgenol 1984; 142: 821-826
• 46 Lang EK, Springer RM, Glorioso LW. 3^rd et al Abdominal abscess drainage under radiologic guidance: causes of failure. Radiology 1986; 159: 329-336
• 47 Sartelli M. A focus on intra-abdominal infections. World J Emerg Surg 2010; 5: 9
• 48 Demetriades D. Total management of the open abdomen. Int Wound J 2012; 9 (Suppl. 01) 17-24
• 49 Sartelli M, Abu-Zidan FM, Catena F. et al Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections: a prospective multicentre study (WISS Study). World J Emerg Surg 2015; 10: 61
• 50 Eckmann C. Antimikrobielle Therapie der Peritonitis im Zeitalter der Multiresistenz. Chirurg 2016; 87: 26-33